All About SGLT Inhibitors for T1D

SGLT inhibitors are oral medications that work by decreasing the production of transport proteins and reducing the absorption of glucose by the intestines and kidneys respectively. Up until now, these drugs have been used exclusively by those with Type 2 diabetes. Inhibitors on the market currently include SGLT-2 inhibitors Farxiga and Jardiance, and Zynquista, the first dual SGLT-1 and SGLT-2 inhibitor.

New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care

The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.

New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.

The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.

Tidepool and Medtronic Announce Collaboration on Interoperable Automated Insulin Pump

Tidepool announced that they have partnered with Medtronic to create an interoperable automated insulin pump system.

Exciting Trial Results for Tandem’s Control-IQ Hybrid Closed Loop System

Participants using Control-IQ saw an increased time in range, lowered HbA1c, and less time in hyperglycemia and hypoglycemia.

Nonprofits Announce Groundbreaking Research Initiative

The Parker Institute, JDRF and The Leona M. and Harry B. Helmsley Charitable Trust announced a research initiative to study immunotherapy-induced diabetes.

Colorado Becomes First State to Pass Bill Capping Insulin Costs

On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.

FDA Approves New Treatment for Diabetic Retinopathy

Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.

Express Scripts Won’t Cover Lilly’s Generic Insulin

The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication.

Previously Healthy from Beyond Type 1 Named Webby People’s Voice Award Winner

Hailed as the “Internet’s highest honor” and “the Oscars of the Internet” The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS) honoring excellence on the Internet.

DIY Loop Now Compatible with Omnipod

Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.

Woman’s Insulin Confiscated By Airport Security

A woman boarding a flight in the UK had her insulin taken from her by airport security and subsequently boarded her flight without it.

Insulin Manufacturers and PBMs Testify Before Congress

The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.

Cigna Plan Could Cap Insulin Costs at $25 a Month

Cigna and Express Scripts announced on Wednesday that they would be lowering the out-of-pocket cost of insulin for some patients with diabetes.

Senseonics Appoints Francine R. Kaufman, M.D. as Chief Medical Officer

Francine R. Kaufman, M.D., a member of Beyond Type 1’s Science Advisory Council, was appointed Chief Medical Officer at Senseonics.